Ventyx Biosciences's market cap is currently ―. The company's EPS TTM is $-3.293; its P/E ratio is -1.32; Ventyx Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -54.03M	$ -53.24M	$ -38.93M	$ -39.88M	$ -30.46M
EBITDA	$ -53.76M	$ -53.10M	$ -38.80M	$ -39.76M	$ -30.34M
Net Income Common Stockholders	$ -54.03M	$ -53.25M	$ -38.93M	$ -35.21M	$ -30.46M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 300.82M	$ 332.25M	$ 376.92M	$ 317.94M	$ 412.42M
Total Assets	$ 321.70M	$ 348.76M	$ 388.58M	$ 371.40M	$ 420.44M
Total Debt	$ 12.33M	$ 1.36M	$ 1.46M	$ 1.56M	$ 1.65M
Net Debt	$ -288.49M	$ -330.89M	$ -375.45M	$ -316.38M	$ -410.78M
Total Liabilities	$ 38.06M	$ 20.96M	$ 17.55M	$ 17.50M	$ 36.91M
Stockholders Equity	$ 283.64M	$ 327.81M	$ 371.62M	$ 353.89M	$ 383.53M
Cash Flow	-
Free Cash Flow	$ -34.71M	$ -49.48M	$ -30.98M	$ -47.38M	$ -24.09M
Operating Cash Flow	$ -34.66M	$ -49.28M	$ -30.92M	$ -47.26M	$ -23.99M
Investing Cash Flow	$ 38.89M	$ 34.82M	$ -18.89M	$ -140.84M	$ 64.16M
Financing Cash Flow	$ 1.63M	$ 2.47M	$ 48.65M	$ -10.36M	$ 177.79M

Currency in USD

Ventyx Biosciences Earnings and Revenue History

Income Statement >

Ventyx Biosciences Debt to Assets

Balance Sheet >

Ventyx Biosciences Cash Flow

Cash Flow >

Ventyx Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing